AKT1 and non-small cell lung carcinoma: On the other hand, other studies indicate that SIRT1 may contribute to the progression of non-small cell lung cancer via the Phosphoinositide 3-Kinase/Protein Kinase B (PI3K/AKT) signaling pathway [55].